Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunic Inc (NQ: IMUX ) 1.610 +0.020 (+1.26%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immunic Inc < Previous 1 2 3 4 5 6 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday October 10, 2023 It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session October 09, 2023 Via Benzinga Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment August 21, 2023 --News Direct-- Via News Direct Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment August 21, 2023 Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion of the enrolment of its phase 2 CALLIPER trial... Via TheNewswire.com Immunic Inc eyeing "big step" for multiple sclerosis patients July 25, 2023 --News Direct-- Via News Direct Immunic Inc set to bring relief with encouraging results May 16, 2023 Immunic Inc set to bring relief with encouraging results Via News Direct Immunic Inc set to bring relief with encouraging results May 16, 2023 Dr Daniel Vitt, CEO of Immunic Inc (NASDAQ:IMUX), discusses the company's encouraging first-quarter performance with Proactive. Via TheNewswire.com Immunic CEO says Q2 results "couldn't be better" August 07, 2023 --News Direct-- Via News Direct Immunic CEO says Q2 results "couldn't be better" August 07, 2023 Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive following the release of the Munich-based biotechnology company's second-quarter financial results and... Via TheNewswire.com Immunic Inc eyeing "big step" for multiple sclerosis patients July 25, 2023 Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive ahead of World Brain Day to provide an update on the biotechnology company's novel multiple sclerosis (MS)... Via TheNewswire.com 12 Health Care Stocks Moving In Wednesday's Intraday Session July 05, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 28, 2023 Via Benzinga Recap: Immunic Q1 Earnings May 11, 2023 Via Benzinga Why Is Immunic (IMUX) Stock Up 23% Today? April 05, 2023 Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial. Via InvestorPlace Preview: Immunic's Earnings February 22, 2023 Via Benzinga Immunic IMU-856 trial data "clearly goes beyond" initial expectations May 04, 2023 Immunic IMU-856 trial data "clearly goes beyond" initial expectations Via News Direct Immunic IMU-856 trial data "clearly goes beyond" initial expectations May 04, 2023 Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at... Via TheNewswire.com Immunic gets a "positive surprise" from lead asset trial April 13, 2023 Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838)... Via TheNewswire.com Immunic gets a "positive surprise" from lead asset trial April 13, 2023 Immunic gets a "positive surprise" from lead asset trial Via News Direct Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 05, 2023 Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... Via Benzinga Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate November 17, 2022 Via Benzinga After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate April 05, 2023 Via Benzinga Why Is Nuvve (NVVE) Stock Down 14% Today? April 05, 2023 Nuvve (NVVE) stock is down on Wednesday after the vehicle-to-grid technology company's shares underwent a rally yesterday. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 05, 2023 Via Benzinga Why Is Secoo (SECO) Stock Down 16% Today? April 05, 2023 Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 05, 2023 We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session December 15, 2022 Via Benzinga BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying November 28, 2022 The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 17, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 17, 2022 We're beginning the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday morning! Via InvestorPlace < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.